SCHEMBL28383104

SCHEMBL28383104

O=C(Nc1cc(CC2CNCCO2)ccc1N1CCCCC1)c1ccc(Br)o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ CSF1R P07333 7/20 0.57
▸ GAA P10253 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ HTT P42858 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ MAPK10 P53779 3/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ MAPT P10636 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ USP2 O75604 1/20 0.52
▸ TSHR P16473 3/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ HPGD P15428 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28887709 0.93 CSF1R (0.57) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL28382809 0.85 PIM1 (0.43) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL28379087 0.85 PIM1 (0.41) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL28378694 0.81 CYP1A2 (0.53) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL20623367 0.78 CYP1A2 (0.69) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL28379118 0.78 PIM1 (0.43) CSF1RGAAHTTALDH1A1MAPK10
SCHEMBL28380085 0.78 PIM1 (0.42) CSF1R
SCHEMBL20598696 0.77 NPC1 (0.64) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL28379474 0.77 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19CSF1RGAA
SCHEMBL20598518 0.77 NPC1 (0.66) CYP1A2CYP2C9CYP2C19CSF1RGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-A Kinase inhibitors and methods of making and using 里格尔药品股份有限公司 2020-04-17 — — CN disclosed
Send feedback